September 5, 2012

EDMONTON, Alberta – September 5, 2012 – Fedora Pharmaceuticals, Inc. today announced the appointment of Thomas Parr, Ph.D. to the newly created role of chief scientific officer. Dr. Parr was most recently chief scientific officer at Targanta Therapeu...

March 30, 2012

EDMONTON, Alberta – March 30, 2012 – Fedora Pharmaceuticals, Inc. today announced the Company’s incorporation and in-license of exclusive worldwide rights to a family of beta-lactamase inhibitors (BLIs) discovered by scientists at NAEJA Pharmaceutica...

Please reload

Featured Posts

Fedora Pharmaceuticals Receives Support from the Government of Canada to Battle Antimicrobial Resistance with Novel Pipeline of Antibiotic Candidates

January 16, 2017

Please reload

Recent Posts
Please reload

Please reload

Follow Us
  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon

11629 – 105 Avenue, Edmonton, AB T5H 0L9  |   780-757-5401

© 2017 Fedora Pharmaceuticals Inc. 

  • Facebook - Black Circle
  • LinkedIn - Black Circle